Read full article on original website
Dec 6 (Reuters) - The European Medicines Agency said on Tuesday its emergency task force has concluded that messenger RNA bivalent COVID-19 vaccines, targeting the original strain and the Omicron BA.4-5 subvariants, may be used in previously unvaccinated children and adults.
Far from being a safe haven from overdoses, jails and prisons are adding fuel to the nation’s behavioral health crisis.
A spokesperson for the Methodist Le Bonheur Healthcare system said Tuesday that gender-affirming procedures for trans patients will continue to be scheduled for the foreseeable future, confirming with The Commercial Appeal after questions were raised about the future of such procedures earlier this month. Initially, the hospital system told Chris Evans, a nonbinary 19-year-old whose procedure was cancelled, that the hospital system was no longer scheduling such procedures, according to the American Civil Liberties Union of...
GREENSBORO, N.C. (WGHP) – When the North Carolina Department of Commerce’s Economic Investment Committee discusses whether to approve incentives to lure new businesses, an economist always reveals the project’s forecast impact on the state’s gross domestic product (GDP). For instance, when the state awarded Toyota $271.4 million in incentives a year ago Tuesday – to […]
Drug overdose deaths among pregnant and postpartum people in the United States have risen sharply in recent years -- especially in 2020, coinciding with the pandemic's onset, a new study says.
Arizona Republicans have plenty of reasons to be disappointed about the outcome of this year’s elections. The party came up short in several key races, thanks in large part to the fact that GOP voters nominated several unqualified extremists, leaving a traditionally red state looking decidedly purple. Among the...
Dec 6 (Reuters) - Pfizer Inc (PFE.N) and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline.